Joe K Gerald

Interests

No activities entered.

Courses

Scholarly Contributions

Journals/Publications

• Burns, J., Rivers, P., LeClair, L. B., Jovel, K. S., Rai, R. P., Lowe, A. A., Edwards, L. J., Khan, S. M., Mathenge, C., Ferraris, M., Kuntz, J. L., Lamberte, J. M., Hegmann, K. T., Odean, M. J., McLeland-Wieser, H., Beitel, S., Odame-Bamfo, L., Schaefer Solle, N., Mak, J., , Phillips, A. L., et al. (2022). Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study. JMIR research protocols, 11(7), e37929.
  More info

  Assessing the real-world effectiveness of COVID-19 vaccines and understanding the incidence and severity of SARS-CoV-2 illness in children are essential to inform policy and guide health care professionals in advising parents and caregivers of children who test positive for SARS-CoV-2.
• Fowlkes, A. L., Yoon, S. K., Lutrick, K., Gwynn, L., Burns, J., Grant, L., Phillips, A. L., Ellingson, K., Ferraris, M. V., LeClair, L. B., Mathenge, C., Yoo, Y. M., Thiese, M. S., Gerald, L. B., Solle, N. S., Jeddy, Z., Odame-Bamfo, L., Mak, J., Hegmann, K. T., , Gerald, J. K., et al. (2022). Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022. MMWR. Morbidity and mortality weekly report, 71(11), 422-428.
  More info

  The BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine was recommended by CDC's Advisory Committee on Immunization Practices for persons aged 12-15 years (referred to as adolescents in this report) on May 12, 2021, and for children aged 5-11 years on November 2, 2021 (1-4). Real-world data on vaccine effectiveness (VE) in these age groups are needed, especially because when the B.1.1.529 (Omicron) variant became predominant in the United States in December 2021, early investigations of VE demonstrated a decline in protection against symptomatic infection for adolescents aged 12-15 years and adults* (5). The PROTECT prospective cohort of 1,364 children and adolescents aged 5-15 years was tested weekly for SARS-CoV-2, irrespective of symptoms, and upon COVID-19-associated illness during July 25, 2021-February 12, 2022. Among unvaccinated participants (i.e., those who had received no COVID-19 vaccine doses) with any laboratory-confirmed SARS-CoV-2 infection, those with B.1.617.2 (Delta) variant infections were more likely to report COVID-19 symptoms (66%) than were those with Omicron infections (49%). Among fully vaccinated children aged 5-11 years, VE against any symptomatic and asymptomatic Omicron infection 14-82 days (the longest interval after dose 2 in this age group) after receipt of dose 2 of the Pfizer-BioNTech vaccine was 31% (95% CI = 9%-48%), adjusted for sociodemographic characteristics, health information, frequency of social contact, mask use, location, and local virus circulation. Among adolescents aged 12-15 years, adjusted VE 14-149 days after dose 2 was 87% (95% CI = 49%-97%) against symptomatic and asymptomatic Delta infection and 59% (95% CI = 22%-79%) against Omicron infection. Fully vaccinated participants with Omicron infection spent an average of one half day less sick in bed than did unvaccinated participants with Omicron infection. All eligible children and adolescents should remain up to date with recommended COVID-19 vaccinations.
• Krings, J. G., Gerald, J. K., Blake, K. V., Krishnan, J. A., Reddel, H. K., Bacharier, L. B., Dixon, A. E., Sumino, K., Gerald, L. B., Brownson, R. C., Persell, S. D., Clemens, C. J., Hiller, K. M., Castro, M., & Martinez, F. D. (2022). A Call for the United States to Accelerate the Implementation of Reliever Combination ICS-Formoterol Inhalers in Asthma. American journal of respiratory and critical care medicine.
• Lowe, A. A., Gerald, J. K., Clemens, C., & Gerald, L. B. (2022). Compliance to a Standardized Protocol for Stock Albuterol Medication among School Staff. The Journal of school nursing : the official publication of the National Association of School Nurses, 10598405221128053.
  More info

  A stock inhaler program provided access to rescue medication (albuterol sulfate) for school children. School staff were provided with a standardized protocol for medication administration. We hypothesized licensed nurses were more likely to report compliant events compared to unlicensed school staff. Stock inhaler events were defined as either compliant or non-compliant. A school protocol compliance score was calculated using the total number of compliant events divided by the total number of all events. The protocol for administration indicated 4 puffs for mild respiratory distress and 8 puffs for severe respiratory distress; therefore, events were defined as compliant if the dose of medication was divisible by 4. A Cragg Poisson hurdle regression was used to examine the association between compliance score and school staff experience. One-hundred fifty-two schools reported 999 stock inhaler events. Of these events, 28% were compliant and 72% of events were non-compliant. After controlling for school organizational type, grades served, and school size, school staff experience was not predictive of protocol compliance. Future efforts should focus on improving protocol compliance among licensed nurses and unlicensed school staff.
• Lowe, A. A., Gerald, J. K., Clemens, C., & Gerald, L. B. (2022). School-based Stock Inhaler Programs and Neighborhood Disadvantage. Journal of health care for the poor and underserved, 33(2), 1083-1093.
  More info

  Ensuring students with asthma residing in disadvantaged communities have access to rescue medication (albuterol) is important.
• Lowe, A. A., Gerald, J. K., Clemens, C., Gaither, C., & Gerald, L. B. (2022). Medication Administration Practices in United States' Schools: A Systematic Review and Meta-synthesis. The Journal of school nursing : the official publication of the National Association of School Nurses, 38(1), 21-34.
  More info

  Schools often provide medication management to children at school, yet, most U.S. schools lack a full-time, licensed nurse. Schools rely heavily on unlicensed assistive personnel (UAP) to perform such tasks. This systematic review examined medication management among K-12 school nurses. Keyword searches in three databases were performed. We included studies that examined: (a) K-12 charter, private/parochial, or public schools, (b) UAPs and licensed nurses, (c) policies and practices for medication management, or (d) nurse delegation laws. Three concepts were synthesized: (a) level of training, (b) nurse delegation, and (c) emergency medications. One-hundred twelve articles were screened. Of these, 37.5% (42/112) were comprehensively reviewed. Eighty-one percent discussed level of training, 69% nurse delegation, and 57% emergency medications. Succinct and consistent policies within and across the United States aimed at increasing access to emergency medications in schools remain necessary.
• Mainardi, A. S., Patel, K. P., Choi, H., Crowder, S. J., & Gerald, J. K. (2022). Advocating for Advocacy in Pulmonary and Critical Care Medicine. Annals of the American Thoracic Society.
• Naleway, A. L., Grant, L., Caban-Martinez, A. J., Wesley, M. G., Burgess, J. L., Groover, K., Gaglani, M., Yoon, S. K., Tyner, H. L., Meece, J., Kuntz, J. L., Yoo, Y. M., Schaefer-Solle, N., Olsho, L. E., Gerald, J. K., Rose, S., Thiese, M. S., Lundgren, J., Groom, H. C., , Mak, J., et al. (2022). Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021. Influenza and other respiratory viruses, 16(3), 585-593.
  More info

  We sought to evaluate the impact of changes in estimates of COVID-19 vaccine effectiveness on the incidence of laboratory-confirmed infection among frontline workers at high risk for SARS-CoV-2.
• Stern, D. A., Lowe, A. A., Clemens, C. J., Lowe, A. A., Stern, D. A., Gerald, L. B., Lowe, A. A., Gerald, J. K., Gerald, L. B., Clemens, C. J., Gerald, J. K., & Clemens, C. J. (2021). Managing respiratory emergencies at school: A county-wide stock inhaler program.. The Journal of allergy and clinical immunology, 148(2), 420-427.e5. doi:10.1016/j.jaci.2021.01.028
  More info

  A total of 15 states allow schools to manage respiratory emergencies among multiple students by using a single albuterol inhaler (stock inhaler) paired with a disposable holding chamber..Our aim was to evaluate implementation barriers and facilitators, as well as satisfaction with a stock inhaler program across K through12 schools in Pima County, Arizona..All public, charter, private, and parochial schools were offered supplies, web-based training, and technical assistance at no cost. The RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework was used to evaluate program implementation. School documentation logs were reviewed, school health personnel were surveyed, and a convenience sample of health personnel were interviewed. Chi-square tests evaluated categoric outcomes and Poisson hurdle regression examined stock inhaler use by school organization type, grade levels served, and type of school health personnel employed..In all, 229 schools (68%) participated, reaching 82% of students in the county. A total of 152 schools (66%) used a stock inhaler, accounting for 1038 events. The mean number of puffs administered was 2.7 (SD = 1.2) per event, and most events (79%) involved students with asthma. Although most events (83.9%) resulted in the student returning to class, 15.6% resulted in students being sent home. Only 6 events resulted in 911 calls, and 5 of these led to an ambulance transport. School health personnel reported high levels of satisfaction, and all schools renewed participation for a second year. Program costs were $156 per school..With technical assistance, stock inhaler programs can be feasibly implemented by schools in a wide range of settings, thereby increasing their capacity to safely manage respiratory emergencies.
• Thomson, C. A., Krupski, L. A., Yuan, N. P., Gerald, J. K., Nair, U. S., & Brady, B. R. (2018). Higher quality quit date coaching enhances quit attempts among quitline callers. Tobacco Prevention & Cessation.
• Yoo, Y. M., Yoo, Y. M., Yoo, Y. M., Yoo, Y. M., Thornburg, N. J., Thornburg, N. J., Thornburg, N. J., Thornburg, N. J., Thompson, M. G., Thompson, M. G., Thompson, M. G., Thompson, M. G., Sun, X., Sun, X., Sun, X., Sun, X., Rivers, P., Rivers, P., Rivers, P., , Rivers, P., et al. (2021). COVID-19 Infection, Reinfection, and Vaccine Effectiveness in a Prospective Cohort of Arizona Frontline/Essential Workers: The AZ HEROES Research Protocol.. JMIR research protocols. doi:10.2196/28925
  More info

  The Arizona Healthcare, Emergency Response, and Other Essential workers Study (AZ HEROES) aims to examine the epidemiology of SARS-CoV-2 infection and COVID-19 illness among adults with high occupational exposure risk..Study objectives include estimating incidence of SARS-CoV-2 infection in essential workers by symptom presentation and demographic factors, determining independent effects of occupational and community exposures on incidence of SARS-CoV-2 infection, establishing molecular and immunologic characteristics of SARS-CoV-2 infection in essential workers, describing the duration and patterns of rRT-PCR-positivity, and examining post-vaccine immunologic response..Eligible participants include Arizona residents aged 18-85 years who work at least 20 hours per week in an occupation involving regular direct contact (within three feet) with others. Recruitment goals are stratified by demographic characteristics (50% aged 40 or older, 50% women, and 50% Hispanic or American Indian), by occupation (40% healthcare personnel, 30% first responders, and 30% other essential workers), and by prior SARS-CoV-2 infection (with up to 50% seropositive at baseline). Information on sociodemographics, health and medical history, vaccination status, exposures to individuals with suspected or confirmed SARS-CoV-2 infection, use of personal protective equipment, and perceived risks are collected at enrollment and updated through quarterly surveys. Every week, participants complete active surveillance for COVID-19-like illness (CLI) and self-collect nasal swabs. Additional self-collected nasal swab and saliva specimens are collected in the event of CLI onset. Respiratory specimens are sent to Marshfield Laboratories and tested for SARS-CoV-2 by real-time reverse transcription polymerase chain reaction (rRT-PCR) assay. CLI symptoms and impact on work and productivity are followed through illness resolution. Serum specimens are collected every 3 months and additional sera are collected following incident rRT-PCR positivity and after each COVID-19 vaccine dose. Incidence of SARS-CoV-2 infections will be calculated by person-weeks at risk and compared by occupation and demographic characteristics and by seropositivity status and infection and vaccination history..The AZ HEROES study was funded by the Centers for Disease Control and Prevention. Enrollment began July 27, 2020 and as of May 1, 2021 a total of 3,165 participants have been enrolled in the study..AZ HEROES is unique in aiming to recruit a diverse sample of essential workers and prospectively following strata of SARS-CoV-2 seronegative and seropositive adults. Survey results combined with active surveillance data on exposure, CLI, weekly molecular diagnostic testing, and periodic serology will be used to estimate the incidence of symptomatic and asymptomatic SARS-CoV-2 infection, assess the intensity and durability of immune responses to natural infection and COVID-19 vaccination, and contribute to the evaluation of COVID-19 vaccine effectiveness..DERR1-10.2196/28925.
• Zunie, T., Zunie, T., Yoon, S. K., Yoon, S. K., Yoo, Y. M., Yoo, Y. M., Wesley, M. G., Wesley, M. G., Tyner, H. L., Tyner, H. L., Thompson, M. G., Thompson, M. G., Thiese, M. S., Thiese, M. S., Sun, X., Sun, X., Stefanski, E. L., Stefanski, E. L., Smith, M. E., , Smith, M. E., et al. (2021). Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.. MMWR. Morbidity and mortality weekly report, 70(13), 495-500. doi:10.15585/mmwr.mm7013e3
  More info

  Messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccines have been shown to be effective in preventing symptomatic COVID-19 in randomized placebo-controlled Phase III trials (1,2); however, the benefits of these vaccines for preventing asymptomatic and symptomatic SARS-CoV-2 (the virus that causes COVID-19) infection, particularly when administered in real-world conditions, is less well understood. Using prospective cohorts of health care personnel, first responders, and other essential and frontline workers* in eight U.S. locations during December 14, 2020-March 13, 2021, CDC routinely tested for SARS-CoV-2 infections every week regardless of symptom status and at the onset of symptoms consistent with COVID-19-associated illness. Among 3,950 participants with no previous laboratory documentation of SARS-CoV-2 infection, 2,479 (62.8%) received both recommended mRNA doses and 477 (12.1%) received only one dose of mRNA vaccine.† Among unvaccinated participants, 1.38 SARS-CoV-2 infections were confirmed by reverse transcription-polymerase chain reaction (RT-PCR) per 1,000 person-days.§ In contrast, among fully immunized (≥14 days after second dose) persons, 0.04 infections per 1,000 person-days were reported, and among partially immunized (≥14 days after first dose and before second dose) persons, 0.19 infections per 1,000 person-days were reported. Estimated mRNA vaccine effectiveness for prevention of infection, adjusted for study site, was 90% for full immunization and 80% for partial immunization. These findings indicate that authorized mRNA COVID-19 vaccines are effective for preventing SARS-CoV-2 infection, regardless of symptom status, among working-age adults in real-world conditions. COVID-19 vaccination is recommended for all eligible persons.
• Press, V. G., & Gerald, J. K. (2020). High-Deductible Health Plans Make the Chronically Ill Pay More for Less.. Annals of the American Thoracic Society, 17(1), 30-31. doi:10.1513/annalsats.201910-808ed
• Brady, B. R., Gerald, J. K., Thomson, C. A., Nair, U. S., Yuan, N. P., & Krupski, L. A. (2019). Higher quality quit date coaching enhances quit attempts among quitline callers. Tobacco, Prevention & Cessation.
• Clemens, C. J., Carvajal, S. C., Billheimer, D., Stefan, N., Moore, M. A., Gerald, L. B., Gerald, J. K., Fisher, J. M., Clemens, C. J., Carvajal, S. C., Bryson, D., Brown, M. A., & Billheimer, D. D. (2019). School-supervised use of a once-daily inhaled corticosteroid regimen: A cluster randomized trial.. The Journal of allergy and clinical immunology, 143(2), 755-764. doi:10.1016/j.jaci.2018.06.048
  More info

  School-supervised use of a once-daily inhaled corticosteroid regimen (supervised therapy) can improve medication adherence and asthma control..We sought to evaluate the effectiveness of supervised therapy in a unique setting and population..We conducted a cluster randomized trial of supervised therapy in 20 elementary schools with a disproportionate enrollment of low-income Latino students. Schools were purposively selected, matched, and randomized to receive 9 months of supervised therapy with mometasone furoate or usual care. All English- or Spanish-speaking students with self-reported asthma were eligible. The Asthma Control Questionnaire (ACQ) was interviewer administered quarterly at school. Students in supervised therapy schools were hypothesized to have lower ACQ scores than students in usual-care schools..Of 393 enrolled students, 189 students receiving immediate intervention and 143 students receiving delayed intervention provided 1 or more ACQ data points, were between 6 and 10 years of age, and were included in the primary analysis. At baseline, 39% of students reported taking a controller medication, and 24% had well-controlled asthma. Eighty percent of students receiving immediate intervention were prescribed mometasone. Schools administered 98% of prescribed doses when students attended school. Absences, weekends, and holidays reduced calendar adherence to 53%. During the first year, the mean ACQ score for students receiving immediate and delayed intervention was 1.55 (95% CI, 1.41-1.70) and 1.64 (95% CI, 1.47-1.80), respectively. The estimated treatment effect was -0.08 (95% CI, -0.31 to 0.14)..Compared with usual care, supervised therapy did not improve asthma control among this population of Latino students. Additional research is warranted to confirm these results.
• Gerald, J. K. (2019). Benefits of Stock Epinephrine Likely Misestimated. JAMA pediatrics.
• Gerald, J. K., & Brady, B. (2019). Time to Make Your Mandatory Attendance Policy Optional. Chronicle of Higher Education.
• Gerald, J. K., Hallmark, B., Billheimer, D., Martinez, F. D., & Gerald, L. B. (2019). Are Latino children of Mexican origin with asthma less responsive to inhaled corticosteroids than white children?. The journal of allergy and clinical immunology. In practice, 7(7), 2419-2421.
• Krupski, L. A., Thomson, C. A., Nair, U. S., Gerald, J. K., Yuan, N. P., & Brady, B. R. (2019). Higher quality quit-date goal setting enhances quit attempts among quitline callers. Tobacco Prevention and Cessation, 5. doi:DOI: https://doi.org/10.18332/tpc/109537
• Papp, E. M., Gerald, J. K., Sadreameli, S. C., & Gerald, L. B. (2019). Why Every School Should Have a Stock Inhaler: One Nurse's Experience. American journal of public health, 109(11), 1528-1529.
• Patel, M., & Gerald, J. K. (2019). Why a Plan to Lower Prescription Drug Prices Should Not Be Piecemeal.. The Conversation (online platform).
• Thomson, C. A., Krupski, L. A., Yuan, N. P., Gerald, J. K., Nair, U. S., & Brady, B. R. (2019). Higher quality quit date coaching enhances quit attempts among quitline callers. Tobacco Prevention & Cessation.
• Thomson, C. A., Krupski, L. A., Yuan, N. P., Gerald, J. K., Nair, U. S., & Brady, B. R. (2019). Higher quality quit-date goal setting enhances quit attempts among quitline callers. Tob Prev & Cessation., 20. doi:DOI: https://doi.org/10.18332/tpc/109537
• Thomson, C. A., Krupskie, L. A., Yuan, N. P., Gerald, J. K., Nair, U. S., & Brady, B. R. (2019). Higher Quality Quit Date Goal Setting Enhances Quit Attempts among Quitline Callers.. Tobacco Prevention and Cessation, 5(20). doi:doi.org/10.18332/tpc/109537
• Verhougstraete, M. P., Gerald, J. K., Gerba, C. P., & Reynolds, K. A. (2019). Cost-benefit of point-of-use devices for lead reduction. Environmental research, 171, 260-265.
  More info

  Lead exposure represents a significant human health concern that often occurs with little warning to the consumer. Water lead levels can be mitigated by point-of-use (POU) devices such as reverse osmosis, distillation, or activated carbon with lead reduction media.
• Gerald, J. K. (2018). Inhaled Glucocorticoids in Asthma. The New England journal of medicine, 378(21), 2049-50.
• Gerald, J. K., & Denninghoff, K. R. (2018). Emergency Department Recidivism and Asthma: Revisiting an Old Problem. The journal of allergy and clinical immunology. In practice, 6(6), 1914-1915.
• Gerald, J. K., Burkholder, B., Strother, J., & Gerald, L. B. (2018). Translating Research into Health Policy: Stock Albuterol Legislation. Annals of the American Thoracic Society, 15(4), 413-416.
• Gerald, J. K., Fisher, J. M., Brown, M. A., Clemens, C. J., Moore, M. A., Carvajal, S. C., Bryson, D., Stefan, N., Billheimer, D., & Gerald, L. B. (2018). School-supervised use of a once-daily inhaled corticosteroid regimen: A cluster randomized trial. The Journal of allergy and clinical immunology.
  More info

  School-supervised use of a once-daily inhaled corticosteroid regimen (supervised therapy) can improve medication adherence and asthma control.
• Gerald, L. B., Strother, J., Burkholder, B., & Gerald, J. K. (2018). Translating Research into Health Policy: Stock Albuterol Legislation. Annals of the American Thoracic Society, 15(4), 413-416.
• Goodwin, J. L., Gerald, L. B., Johnson, J. L., & Gerald, J. K. (2018). Use of a disposable valved-holding chamber (spacer) in a school-based asthma trial. The journal of allergy and clinical immunology. In practice, 6(1), 307-309.
• Patel, M. R., Press, V. G., Gerald, L. B., Barnes, T., Blake, K., Brown, L. K., Costello, R. W., Crim, C., Forshag, M., Gershon, A. S., Goss, C. H., Han, M. K., Lee, T. A., Sweet, S., & Gerald, J. K. (2018). Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease. An Official American Thoracic Society Policy Statement. American journal of respiratory and critical care medicine, 198(11), 1367-1374.
  More info

  Mounting evidence indicates that out-of-pocket costs for prescription medications, particularly among low- and middle-income patients with chronic diseases, are imposing financial burden, reducing medication adherence, and worsening health outcomes. This problem is exacerbated by a paucity of generic alternatives for prevalent lung diseases, such as asthma and chronic obstructive pulmonary disease, as well as high-cost medicines for rare diseases, such as cystic fibrosis. Affordability and access challenges are especially salient in the United States, as citizens of many other countries pay lower prices for and have greater access to prescription medications.
• Reynolds, K. A., Gerba, C. P., Gerald, J. K., & Verhougstraete, M. (2019). Cost-benefit of point-of-use devices for lead reduction. Environmental Research.
• Gerald, J. K. (2017). Generic Competition for Orally Inhaled Respiratory Medications. Two Steps Forward, One Step Back. Annals of the American Thoracic Society, 14(2), 165-167.
• Gerald, J. K. (2017). Generic Competition for Orally Inhaled Respiratory Medications: Two Steps Forward, One Step Back. Annals American Thoracic Society, 14(3), 165-167. doi:10.1513/AnnalsATS.201607-569PS
• Gerald, J. K. (2017). Ten Principles to Guide Health Reform. Annals of the American Thoracic Society, 14(3), 420-425.
  More info

  Americans face inevitable trade-offs between health care affordability, accessibility, and innovation. Although numerous reforms have been proposed, universal principles to guide decision-making are lacking. Solving the challenges that confront us will be difficult, owing to intense partisan divisions and a dysfunctional political process. Nevertheless, we must engage in reasoned debate that respects deeply held differences of opinion regarding our individual and collective obligations to promote healthy living and ensure affordable access to health care. Otherwise, our decisions will be expressed through political processes that reflect the preferences of narrow interests rather than the general public. Our health care system can be made more efficient and equitable by incentivizing consumers and providers to utilize high-value care and avoid low-value care. To accomplish this, we must understand the determinants of consumer and provider behavior and implement policies that encourage, but do not force, optimal decision-making. Although distinguishing between low- and high-value treatments will invariably threaten established interests, we must expand our capacity to make such judgements. Throughout this process, consumers, taxpayers, and policy makers must maintain realistic expectations. Although realigning incentives to promote high-value care will improve efficiency, it is unlikely to control increasing medical expenditures because they are not primarily caused by inefficiency. Rather, rising medical expenditures are driven by medical innovation made possible by increasing incomes and expanding health insurance coverage. Failure to recognize these linkages risks adopting indiscriminate policies that will reduce spending but slow innovation and impair access to needed care.
• Gerald, J. K. (2017). The Benefit of Early Preventive Dental Care for Children. JAMA pediatrics, 171(9), 916.
• Bime, C., Gerald, J. K., Wei, C. Y., Holbrook, J. T., Teague, W. G., Wise, R. A., & Gerald, L. B. (2016). Measurement characteristics of the childhood Asthma-Control Test and a shortened, child-only version. NPJ primary care respiratory medicine, 26, 16075.
  More info

  The childhood Asthma-Control Test (C-ACT) is validated for assessing asthma control in paediatric asthma. Among children aged 4-11 years, the C-ACT requires the simultaneous presence of both parent and child. There is an unmet need for a tool that can be used to assess asthma control in children when parents or caregivers are not present such as in the school setting. We assessed the psychometric properties and estimated the minimally important difference (MID) of the C-ACT and a modified version, comprising only the child responses (C-ACTc). Asthma patients aged 6-11 years (n=161) from a previously completed multicenter randomised trial were included. Demographic information, spirometry and questionnaire scores were obtained at baseline and during follow-up. Participants or their guardians kept a daily asthma diary. Internal consistency reliabilities of the C-ACT and C-ACTc were 0.76 and 0.67 (Cronbach's α), respectively. Test-retest reliabilities of the C-ACT and C-ACTc were 0.72 and 0.66 (intra-class correlation), respectively. Significant correlations were noted between C-ACT scores and ACQ scores (Spearman's correlation r=-0.56, 95% CI (-0.66, -0.44), P
• Chongpison, Y., Hornbrook, M. C., Harris, R. B., Herrinton, L. J., Gerald, J. K., Grant, M., Bulkley, J. E., Wendel, C. S., & Krouse, R. S. (2016). Self-reported depression and perceived financial burden among long-term rectal cancer survivors. Psycho-oncology.
  More info

  Types of surgery for rectal cancer (RC), including permanent ostomy (PO) or temporary ostomy followed by anastomosis (TO) or initial anastomosis (AN), can affect psychological and financial well-being during active treatment. However, these relationships have not been well studied among long-term survivors (≥5 years post-diagnosis).
• Gerald, J. K., & Gerald, L. B. (2016). The Unfulfilled Promise of School-Centered Asthma Care. The journal of allergy and clinical immunology. In practice, 4(5), 980-1.
• Gerald, J. K., & Moreno, F. A. (2016). Asthma and Depression: It's Complicated. The journal of allergy and clinical immunology. In practice, 4(1), 74-5.
• Gerald, L. B., Snyder, A., Disney, J., Gerald, J. K., Thomas, A., Wilcox, G., & Brown, M. A. (2016). Implementation and Evaluation of a Stock Albuterol Program for Students with Asthma. Annals of the American Thoracic Society, 13(2), 295-6.
• Huthayfa, A., Bime, C., & Gerald, J. K. (2016). Tucson Critical Care Journal Club: Albumin Use in the Critical Care Unit. Southwest J Pulm Crit Care.
• Weiss, C. H., Krishnan, J. A., Au, D. H., Bender, B. G., Carson, S. S., Cattamanchi, A., Cloutier, M. M., Cooke, C. R., Erickson, K., George, M., Gerald, J. K., Gerald, L. B., Goss, C. H., Gould, M. K., Hyzy, R., Kahn, J. M., Mittman, B. S., Mosesón, E. M., Mularski, R. A., , Parthasarathy, S., et al. (2016). An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine. American journal of respiratory and critical care medicine, 194(8), 1015-1025.
  More info

  Many advances in health care fail to reach patients. Implementation science is the study of novel approaches to mitigate this evidence-to-practice gap.
• Bender, B. G., Krishnan, J. A., Chambers, D. A., Cloutier, M. M., Riekert, K. A., Rand, C. S., Schatz, M., Thomson, C. C., Wilson, S. R., Apter, A., Carson, S. S., George, M., Gerald, J. K., Gerald, L., Goss, C. H., Okelo, S. O., Mularski, R. A., Nguyen, H. Q., Patel, M. R., , Szefler, S. J., et al. (2015). American Thoracic Society and National Heart, Lung, and Blood Institute Implementation Research Workshop Report. Annals of the American Thoracic Society, 12(12), S213-21.
  More info

  To advance implementation research (IR) in respiratory, sleep, and critical care medicine, the American Thoracic Society and the Division of Lung Diseases from the NHLBI cosponsored an Implementation Research Workshop on May 17, 2014. The goals of IR are to understand the barriers and facilitators of integrating new evidence into healthcare practices and to develop and test strategies that systematically target these factors to accelerate the adoption of evidence-based care. Throughout the workshop, presenters provided examples of IR that focused on the rate of adoption of evidence-based practices, the feasibility and acceptability of interventions to patients and other stakeholders who make healthcare decisions, the fidelity with which practitioners use specific interventions, the effects of specific barriers on the sustainability of an intervention, and the implications of their research to inform policies to improve patients' access to high-quality care. During the discussions that ensued, investigators' experience led to recommendations underscoring the importance of identifying and involving key stakeholders throughout the research process, ensuring that those who serve as reviewers understand the tenets of IR, managing staff motivation and turnover, and tackling the challenges of scaling up interventions across multiple settings.
• Dill, J., Gerald, J. K., Bime, C., & Knepler, J. L. (2015). September 2015 Tucson pulmonary journal club: genomic classifier for lung cancer. .. Southwest J Pulm Crit Care. doi:doi: http://dx.doi.org/10.13175/swjpcc125-15 PDF
• Dill, J., Gerald, J. K., Bime, C., & Knepler, J. L. (2015). Tucson pulmonary journal club: genomic classifier for lung cancer.. Southwest J Pulm Crit Care.
• Ganesh, A., Bime, C., & Gerald, J. K. (2015). Tucson pulmonary journal club: fibrinolysis for Pulmonary Embolus. Southwest J Pulm Crit Care.
• Gerald, J. K. (2015). February 2015 Tucson pulmonary journal club: fibrinolysis for PE. Southwest J Pulm Crit Care.
  More info

  Ganesh A, Bime C, Gerald J. February 2015 Tucson pulmonary journal club: fibrinolysis for PE. Southwest J Pulm Crit Care. 2015;10(2):97-8.
• Gerald, J. K. (2015). January 2015 Tucson pulmonary journal club: withdrawal of inhaled glucocorticoids in COPD. Southwest J Pulm Crit Care.
  More info

  Nahapetian RR, Gerald J. November 2015 Tucson critical care journal club: atrial fibrillation in sepsis. Southwest J Pulm Crit Care. 2015;11(6):266-8
• Gerald, J. K. (2015). November 2015 Tucson critical care journal club: atrial fibrillation in sepsis. Southwest J Pulm Crit Care. Southwest J Pulm Crit Care.
  More info

  Nahapetian RR, Gerald J. November 2015 Tucson critical care journal club: atrial fibrillation in sepsis. Southwest J Pulm Crit Care. 2015;11(6):266-8
• Gerald, J. K. (2015). September 2015 Tucson pulmonary journal club: A bronchial genomic classifier. Southwest J Pulm Crit Care.
  More info

  Dill J, Gerald J, Bime C, Knepler J. September 2015 Tucson pulmonary journal club: A bronchial genomic classifier. Southwest J Pulm Crit Care. 2015;11:119-120.
• Gerald, J. K., Carr, T. F., Wei, C. Y., Holbrook, J. T., & Gerald, L. B. (2015). Albuterol Overuse: A Marker of Psychological Distress?. The journal of allergy and clinical immunology. In practice, 3(6), 957-62.
  More info

  Albuterol overuse, 3 or more canisters per year, is associated with poor asthma control and frequent exacerbations.
• Gerald, J. K., Gerald, L. B., Vasquez, M. M., Morgan, W. J., Boehmer, S. J., Lemanske, R. F., Mauger, D. T., Strunk, R. C., Szefler, S. J., Zeiger, R. S., Bacharier, L. B., Bade, E., Covar, R. A., Guilbert, T. W., Heidarian-Raissy, H., Kelly, H. W., Malka-Rais, J., Sorkness, C. A., Taussig, L. M., , Chinchilli, V. M., et al. (2015). Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma. The journal of allergy and clinical immunology. In practice, 3(4), 540-6.e3.
  More info

  Inhaled corticosteroids are recommended as first-line therapy for children with mild persistent asthma; however, specific patient characteristics may modify the treatment response.
• Gerald, J. K., Wechsler, M. E., & Martinez, F. D. (2014). Asthma medications should be available for over-the-counter use: pro. Annals of the American Thoracic Society, 11(6), 969-74.
  More info

  Medications that provide quick relief of symptoms and that control airway inflammation are the mainstays of asthma treatment. However, adherence to these medications is suboptimal. The inconvenience and costs associated with obtaining these prescription-only medications are factors that contribute to poor adherence. The Food and Drug Administration recently requested public comment on a new paradigm whereby specific prescription-only medications could be made available over the counter, provided that conditions for their safe use could be established. Many organizations expressed opposition, including the American Thoracic Society and other societies representing patients with respiratory diseases. These organizations cited unsubstantiated benefits and unnecessary risks as reasons to oppose greater over-the-counter availability of current prescription-only medications. This article examines the rationale for, and potential ramifications of, making asthma medications available for nonprescription use.
• Natt, B., Berry, C. E., Bime, C., & Gerald, J. K. (2014). Tucson critical care journal club: early goal-directed therapy. Southwest J Pulm Crit Care.
• Natt, B., Berry, C. E., Bime, C., & Gerald, J. K. (2014). Tucson critical care journal club: early goal-directed therapy. Southwest Journal of Pulmonary and Critical Care.
• Strawter, C., Berry, C. E., Bime, C., & Gerald, J. K. (2014). Tucson critical care journal club: esmolol in septic shock. Southwest J Pulm Crit Care.
• Wechsler, M. E., Martinez, F. D., & Gerald, J. K. (2014). Reply: safety of short-acting β-agonists not a barrier to making asthma rescue and controller medications available over the counter.. Annals of the American Thoracic Society, 11(7), 1162-3. doi:10.1513/annalsats.201407-318le
• Carson, S. S., Goss, C. H., Patel, S. R., Anzueto, A., Au, D. H., Elborn, S., Gerald, J. K., Gerald, L. B., Kahn, J. M., Malhotra, A., Mularski, R. A., Riekert, K. A., Rubenfeld, G. D., Weaver, T. E., Krishnan, J. A., & , A. T. (2013). An official American Thoracic Society research statement: comparative effectiveness research in pulmonary, critical care, and sleep medicine. American journal of respiratory and critical care medicine, 188(10).
  More info

  Comparative effectiveness research (CER) is intended to inform decision making in clinical practice, and is central to patient-centered outcomes research (PCOR).
• Gerald, J. K., McClure, L. A., Harrington, K. F., Moore, T., Hernández-Martínez, A. C., & Gerald, L. B. (2012). Measurement characteristics of the pediatric asthma health outcome measure. The Journal of asthma : official journal of the Association for the Care of Asthma, 49(3), 260-6.
  More info

  The Pediatric Asthma Health Outcome Measure (PAHOM) was designed to measure quality-adjusted life years (QALYs) in children with asthma. Our objective was to compare parent- and child-reported PAHOM scores to each other, to parent-reported scores on the Juniper Asthma Control Questionnaire (ACQ), and to physician-rated asthma control.
• Gerald, J. K., Stroupe, N., McClure, L. A., Wheeler, L., & Gerald, L. B. (2012). Availability of Asthma Quick Relief Medication in Five Alabama School Systems. Pediatric allergy, immunology, and pulmonology, 25(1), 11-16.
  More info

  OBJECTIVES: This paper documents individual asthma action plan presence and quick relief medication (albuterol) availability for elementary students enrolled in five Alabama school systems. PATIENTS AND METHODS: Data were obtained during baseline data collection (fall 2005) of a school-based supervised asthma medication trial. All students attended 1 of 36 participating elementary schools across five school systems in Jefferson County, Alabama. In addition, they had to have physician-diagnosed asthma requiring daily controller medication. Each school system had its own superintendent and elected school board. Asthma action plan presence and albuterol availability was confirmed by study personnel. Asthma action plans had to contain daily and acute asthma management instructions. Predictors of asthma action plan presence and albuterol availability were also investigated. Associations between albuterol availability and self-reported characteristics including health care utilization prior to study enrollment and outcomes during the study baseline period were also investigated. RESULTS: Enrolled students had a mean (SD) age of 11.0 (2.1) years, 91% were African American, and 79% had moderate persistent asthma. No student had a complete asthma action plan on file and only 14% had albuterol physically available at school. Albuterol availability was not predicted by gender, race, insurance status, second-hand smoke exposure, need for pre-exercise albuterol, asthma severity, or self-reported health care utilization prior to study enrollment. Albuterol availability did not predict school absences, red/yellow peak flow recordings, or medication adherence during the study's baseline period. CONCLUSION: Despite policies permitting students to possess albuterol, few elementary students across five independent school systems in Alabama actually had it readily available at school.
• Gerald, L. B., Gerald, J. K., Zhang, B., McClure, L. A., Bailey, W. C., & Harrington, K. F. (2012). Can a school-based hand hygiene program reduce asthma exacerbations among elementary school children?. The Journal of allergy and clinical immunology, 130(6), 1317-24.
  More info

  Viral upper respiratory tract infections have been implicated as a major cause of asthma exacerbations among school-aged children. Regular hand washing is the most effective method to prevent the spread of viral respiratory tract infections, but effective hand-washing practices are difficult to establish in schools.
• Nuño, T., Gerald, J. K., Harris, R., Martinez, M. E., Estrada, A., & García, F. (2012). Comparison of breast and cervical cancer screening utilization among rural and urban Hispanic and American Indian women in the Southwestern United States. Cancer causes & control : CCC, 23(8), 1333-41.
  More info

  Rural Hispanic and American Indian (AI) women are at risk of non-participation in cancer screening programs. The objective of this study was to compare breast and cervical cancer screening utilization among Hispanic and AI women that reside in rural areas of the Southwestern United States to their urban counterparts and to assess characteristics that influence cancer screening.
• Funkhouser, E., Levine, D. A., Gerald, J. K., Houston, T. K., Johnson, N. K., Allison, J. J., & Kiefe, C. I. (2011). Recruitment activities for a nationwide, population-based, group-randomized trial: the VA MI-Plus study. Implementation science : IS, 6, 105.
  More info

  The Veterans Health Administration (VHA) oversees the largest integrated healthcare system in the United States. The feasibility of a large-scale, nationwide, group-randomized implementation trial of VHA outpatient practices has not been reported. We describe the recruitment and enrollment of such a trial testing a clinician-directed, Internet-delivered intervention for improving the care of postmyocardial infarction patients with multiple comorbidities.
• Gerald, L. B., Gerald, J. K., McClure, L. A., Harrington, K., Erwin, S., & Bailey, W. C. (2011). Redesigning a large school-based clinical trial in response to changes in community practice. Clinical trials (London, England), 8(3), 311-9.
  More info

  Asthma exacerbations are seasonal with the greatest risk in elementary-age students occurring shortly after returning to school following summer break. Recent research suggests that this seasonality in children is primarily related to viral respiratory tract infections. Regular hand washing is the most effective method to prevent the spread of viral respiratory infections; unfortunately, achieving hand washing recommendations in schools is difficult. Therefore, we designed a study to evaluate the effect of hand sanitizer use in elementary schools on exacerbations among children with asthma.
• Levine, D. A., Funkhouser, E. M., Houston, T. K., Gerald, J. K., Johnson-Roe, N., Allison, J. J., Richman, J., & Kiefe, C. I. (2011). Improving care after myocardial infarction using a 2-year internet-delivered intervention: the Department of Veterans Affairs myocardial infarction-plus cluster-randomized trial. Archives of internal medicine, 171(21), 1910-7.
  More info

  Cardiovascular risk reduction in ambulatory patients who survive myocardial infarction (MI) is effective but underused. We sought to evaluate a provider-directed, Internet-delivered intervention to improve cardiovascular management for post-MI outpatients.
• Gerald, J. K., Grad, R., Bailey, W. C., & Gerald, L. B. (2010). Cost-effectiveness of school-based asthma screening in an urban setting. The Journal of allergy and clinical immunology, 125(3), 643-50, 650.e1-650.e12.
  More info

  Much has been done to promote population-based childhood asthma screening; however, concerns remain regarding its cost-effectiveness.
• Gerald, J. K., Sun, Y., Grad, R., & Gerald, L. B. (2009). Asthma morbidity among children evaluated by asthma case detection. Pediatrics, 124(5), e927-33.
  More info

  Population-based asthma detection is a potential strategy to reduce asthma morbidity in children; however, the burden of respiratory symptoms and health care use among children identified by case detection is not well known.
• Gerald, L. B., Gerald, J. K., Gibson, L., Patel, K., Zhang, S., & McClure, L. A. (2009). Changes in environmental tobacco smoke exposure and asthma morbidity among urban school children. Chest, 135(4), 911-6.
  More info

  Environmental tobacco smoke (ETS) exposure is associated with poor asthma outcomes in children. However, little is known about natural changes in ETS exposure over time in children with asthma and how these changes may affect health-care utilization. This article documents the relationship between changes in ETS exposure and childhood asthma morbidity among children enrolled in a clinical trial of supervised asthma therapy.

Proceedings Publications

• Lowe, A. A., Todacheenie, S., Lowe, A. A., Liu, A. H., Lee, A., Jones, C., Jim, S., Gerald, L. B., Gerald, J. K., Bender, B. G., & Begay, C. (2020). Indoor Environmental Exposures and Asthma Control Among Navajo Children in Tuba City, Arizona - NNHRRB Approval #NNR-16.247. In B102. CARING FOR LUNG DISEASES IN UNDERSERVED AND VULNERABLE POPULATIONS.
• Lowe, A. A., Clemens, C. J., Lowe, A. A., Gerald, L. B., Gerald, J. K., & Clemens, C. J. (2019). Implementation of a County-Wide Stock Inhaler for Schools Program in Pima County, Arizona. In B102. DISPARITIES IN ASTHMA MANAGEMENT.
• Lowe, A. A., Phan, H., Phan, H., Lowe, A. A., Gerald, L. B., Gerald, J. K., Black, S., Bender, B. G., & Begay, J. (2019). Caregiver Reported Asthma Outcomes of School-Age Navajo Children in Tuba City, Arizona. In B102. DISPARITIES IN ASTHMA MANAGEMENT.

Presentations

• Gerald, L. B., Bender, B., Phan, H., Begay, J., Black, S., Gerald, J. K., & Lowe, A. (2018, May). Caregiver Reported Asthma Outcomes of School Age Navajo Children in Tuba City, AZ. American Thoracic Society. Dallas, TX.
• Gerald, L. B., Clemens, C. J., Gerald, J. K., & Lowe, A. (2019, June). Implementation for a County Wide Stock INhaler Program for Schools in Pima County, AZ. Arizona Academy of Pediatrics. Sedona, AZ.
• Gerald, L. B., Clemens, C. J., Gerald, J. K., & Lowe, A. (2019, May). Implementation of a County Wide Stock INhaler Program in Pima County, Arizona. American Thoracic Society International Conference. Dallas, TX.
• Gerba, C. P., Reynolds, K. A., Gerald, J. K., & Verhougstraete, M. (2019, June). Cost-Benefit of Point of Use Devices for Lead Reductions. American Water Works Association ACE 2019. Denver, CO: WQRF.
• Gerald, J. K., Fisher, J., Billheimer, D., Brown, M., Clemens, C. J., Moore, M. A., & Gerald, L. B. (2018, May). Controller Medication Prescribing and Adherence among Medicaid Insured Children Enrolled in the Supervised Asthma Medicine in Schools Study. American Thoracic Society International Conference. San Diego.
• Gerald, J. K., Hallmark, B., Billheimer, D., Martinez, F., & Gerald, L. B. (2018, May). Are Hispanic Children of Mexican Origin Less Responsive to ICS treatment than non-Hispanic White Children? A Meta-Analysis of CARE Trials.. American Thoracic Society International Conference. San Diego, California.
• Gerald, L. B., Gerald, J. K., Clemens, C. J., Snyder, A., Cardenas, K. R., & Lowe, A. (2018, Fall). The Pima County Stock Inhaler for Schools Program: Using Policy to Improve Child Health. Oregon Public Health Association. Portland Oregon: Oregon Public Health Association.
• Gerald, L. B., Martinez, F., Billheimer, D. D., Hallmark, B., & Gerald, J. K. (2018, May). Are hispanic children of mexican origin less responsive to ICS treatment than non-hispanic white children: A Meta-Analysis of CARE trials. American Thoracic Society International Conference. San Diego, CA: American Thoracic Society.
• Gerald, L. B., Moore, M. A., Clemens, C. J., Brown, M., Billheimer, D. D., Fisher, J., & Gerald, J. K. (2018, May). Controller medication prescribing and adherence among medicaid insured children enrolled in the supervised asthma medicine in schools study. American Thoracic Society International Conference. San Diego, CA: American Thoracic Society.
• Gerald, L. B., Carvajal, S. C., Billheimer, D. D., Fisher, J., Gerald, J. K., & Lowe, A. (2017, May). Among children with asthma, greater acculturation is associated with having a medical home. American Thoracic Society International Conference. Washington, DC: American Thoracic Society.
• Gerald, L. B., Stefan, N., Bryson, D., Carvajal, S. C., Moore, M. A., Clemens, C. J., Billheimer, D. D., Fisher, J., Brown, M., & Gerald, J. K. (2017, May). Supervised Medicine in Schools: The SAMS Study. American Thoracic Society International Conference. Washington, DC: American Thoracic Society.
• David*, S., Gerald, L. B., Jenkins, I., Clemens, C. J., Brown, M. A., Billheimer, D., Goodwin, J., Johnson, D., Bryson, D., & Gerald, J. K. (2015, May). School-Based Asthma Management Programs Could Provide a Source of Care for Children Who Otherwise Lack Access. American Thoracic Society. Denver, CO: American Thoracic Society.

Poster Presentations

• Gerald, L. B., Bender, B., Phan, H., Begay, J., Black, S., Gerald, J. K., & Lowe, A. A. (2019, Fall). Caregiver Reported Asthma Outcomes of School-Age Navajo Children in Tuba City, Arizona.. American Thoracic Society (ATS) Annual ConferenceAmerican Thoracic Society (ATS).
• Oren, E., Oren, E., Oren, E., Combs, D. A., Combs, D. A., Combs, D. A., Fisher, J., Fisher, J., Fisher, J., Goodwin, J., Goodwin, J., Goodwin, J., Billheimer, D. D., Billheimer, D. D., Billheimer, D. D., Gerald, J. K., Gerald, J. K., Gerald, J. K., Clemens, C. J., , Clemens, C. J., et al. (2016, May). Impact of supervised asthma medication use on sleep outcomes of elementary school children. 2016 International Meeting of the American Thoracic Society. San Francisco, CA.
• Gerald, J. K. (2015, May). Association Between Health Insurance Status and Baseline Clinical and Demographic Characteristics among Hispanic Children Enrolled in the Supervised Asthma Medication in Schools (SAMS) Study. 2015 American Thoracic Society International Conference. Denver, CO: American Thoracic Society.
  More info

  Valencia C, Gerald LB, Jenkins I, Billheimer D, Moore M, Goodwin JL, Aguilar P, Bryson D, Johnson D, Gerald JK. Association Between Health Insurance Status and Baseline Clinical and Demographic Characteristics among Hispanic Children Enrolled in the Supervised Asthma Medication in Schools (SAMS) Study. Am J Respir Crit Care Med TBA. Presented at 2015 American Thoracic Society International Conference. Denver, CO.
• Gerald, J. K. (2015, May). Association between Body Mass Index and Baseline Clinical and Demographic Characteristics among Hispanic Children Enrolled in the Supervised Asthma Medication in Schools (SAMS) Study. 2015 American Thoracic Society International Conference. Denver, CO: American Thoracic Society.
  More info

  Gerald JK, Brown MA, Clemens C, Jenkins I, Billheimer D, Goodwin JL, Johnson D, Bryson D, Snyder A, Gerald LB. Association between Body Mass Index and Baseline Clinical and Demographic Characteristics among Hispanic Children Enrolled in the Supervised Asthma Medication in Schools (SAMS) Study. Am J Respir Crit Care Med TBA. Presented at 2015 American Thoracic Society International Conference. Denver, CO.
• Gerald, J. K. (2015, May). School-Based Asthma Management Programs Could Provide a Source of Care for Children Who Otherwise Lack Access. 2015 American Thoracic Society International Conference. Denver, CO: American Thoracic Society.
  More info

  David S, Gerald LB, Jenkins I, Clemens C, Brown MA, Billheimer D, Goodwin JL, Johnson D, Bryson D, Gerald JK. School-Based Asthma Management Programs Could Provide a Source of Care for Children Who Otherwise Lack Access. Am J Respir Crit Care Med TBA. Presented at 2015 American Thoracic Society International Conference. Denver, CO.
• Gerald, J. K. (2015, May). Sleep Symptoms in a Population of 5-11 Year Old Children with Asthma Enrolled in the Supervised Asthma Medicine in Schools (SAMS) Study. 2015 Associated Professional Sleep Societies Meeting.
  More info

  Goodwin JL, Gerald JK, Brown MA, Clemens CJ, Jenkins IC, Gerald LB. Sleep Symptoms in a Population of 5-11 Year Old Children with Asthma Enrolled in the Supervised Asthma Medicine in Schools (SAMS) Study. Presented at 2015 Associated Professional Sleep Societies Meeting.
• Gerald, J. K., Brown, M. A., Clemens, C. J., Jenkins, I., Fisher*, J., Billheimer, D., Goodwin, J., Johnson, D., Bryson, D., Snyder*, A., & Gerald, L. B. (2015, May). Association Between BMI and Baseline Demographic Characteristics among Hispanic Children with Asthma. American Thoracic Society. Denver, CO: American Thoracic Society.
• Valencia*, C., Gerald, L. B., Jenkins, I., Fisher*, J., Billheimer, D., Moore, M. A., Goodwin, J., Aguilar, P., Bryson, D., Johnson, D., Gerald, J. K., Valencia*, C., Gerald, L. B., Jenkins, I., Fisher*, J., Billheimer, D., Moore, M. A., Goodwin, J., Aguilar, P., , Bryson, D., et al. (2015, May). Association Between Health Insurance Status and Clinical and Demographic Characteristics Among Hispanic Children with Asthma. American Thoracic Society. Denver, CO: American Thoracic Society.

Others

• Gerald, J. K., Wechsler, M. E., & Martinez, F. D. (2014, Sep). Reply: safety of short-acting β-agonists not a barrier to making asthma rescue and controller medications available over the counter. Annals of the American Thoracic Society.